In Europe, the first reports of lung-cancer–specific EGFR mutations were described in Italy, and showed EGFR mutations in 10% of 375 lung adenocarcinomas [27], whereas in Spain it was described a rate of EGFR mutations of 16.6% [19]. This evidence concerns the gene EGFR and lung cancer.